Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation
Data up to Jan 2025
Total Citations Per Year
Abstract
References (8)
Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 Patients
1993 • 1,173 citations
Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors
1984 • 845 citations
Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.
1993 • 257 citations
Treatment of Hepatic Venocclusive Disease With Recombinant Human Tissue Plasminogen Activator and Heparin in 42 Marrow Transplant Patients
1997 • 189 citations
Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules.
1987 • 184 citations
THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATION
1985 • 159 citations
Recombinant human tissue plasminogen activator for the treatment of established severe venocclusive disease of the liver after bone marrow transplantation
1992 • 101 citations
Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).
1990 • 58 citations
Cited By (0)
No citing papers found in database